Abstract
Remdesivir and Lopinavir/Ritonavir as Potential Drugs to Treat Coronavirus Disease 2019 (COVID-19)
Drugs that are efficacious against SARS-CoV-2 have yet to be established. Remdesivir and Lopinavir/ritonavir have garnered considerable attention for their potential to treat coronavirus disease 2019 (COVID-19).
Remdesivir not only in vivo but also in vitro testing shows the inhibition of human coronavirus replication, including SARS-CoV-2 as well as Lopinavir/ritonavir that shows promising antiviral drug against SARS-CoV-2.
Author(s):
Bzikha Reda*, Bouhmou Ayoub, Bzikha Ilham, Bouchnafati Sanaa
Abstract | Full-Text | PDF
Share this
Awards Nomination
Google scholar citation report
Citations : 196
Journal of Preventive Medicine received 196 citations as per google scholar report
Abstracted/Indexed in
- Google Scholar
- China National Knowledge Infrastructure (CNKI)
- Secret Search Engine Labs
- Euro Pub
Open Access Journals
- Aquaculture & Veterinary Science
- Chemistry & Chemical Sciences
- Clinical Sciences
- Engineering
- General Science
- Genetics & Molecular Biology
- Health Care & Nursing
- Immunology & Microbiology
- Materials Science
- Mathematics & Physics
- Medical Sciences
- Neurology & Psychiatry
- Oncology & Cancer Science
- Pharmaceutical Sciences